정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 275 | Not yet recruiting | The COvid-19 Symptom MOntelukast Trial | COVID-19 | Drug: Montelukast 10mg | Phase 3 | McGill University, Lady Davis Institute | OTHER | 600 | All | 40 Years | |
| 274 | Recruiting | The COVID-RASi Trial (COVID-19) | Cardiovascular Diseases | Drug: Angiotensin converting enzyme inhibitor Drug: Angiotensin II Receptor Blockers |
Phase 3 | Ottawa Heart Institute Research Corporation | OTHER | 1155 | All | 40 Years | Centro de Pesquisa Clinicas Dr Marco Mota, Maceio, Alagoas, Brazil Santa Casa de Itabuna, Itabuna, Bahia, Brazil Hospital Felicio Rocho, Belo Horizonte, MG, Brazil Centro de Pesquisa Clinica da Unimed Campo Grande, Campo Grande, MG, Brazil Clinica de Campo Grande, Campo Grande, MG, Brazil Hospital Agamenom Magalhaes, Recife, PE, Brazil Pronto Socorro Cardiologico de Pernambuco Recife, Recife, PE, Brazil Instituto Atena de Pesquisa Clinica, Natal, RN, Brazil Hospital Universitar Canoas, Canoas, RS, Brazil Hospital Sao Vicente de Paulo, Passo Fundo, RS, Brazil Instituto de Pesquisa Clinica de Campinas, Campinas, SP, Brazil Hospital Bela Vista, Consolacao, SP, Brazil Instituto Prevent Senior, Sao Paulo, SP, Brazil Instituto de Coracao, Sao Paulo, SP, Brazil Instituto Goiano de Oncologia e Hematologia, Goiania, Brazil Alberta Health Services, Edmonton, Alberta, Canada University of Ottawa Heart Institute, Ottawa, Ontario, Canada Hospital General 1, IMSS, Ciudad de Mexico, Mexico Hospital General de zona 27- IMSS, Ciudad de Mexico, Mexico |
| 273 | Withdrawn | The Danish Pre-HCQ COVID Dialysis Study | End Stage Renal Disease | Drug: Hydroxychloroquine | Phase 4 | Nicholas Carlson | OTHER | 0 | All | 18 Years | Rigshospitalet, Copenhagen, Denmark Herlev Hospital, Herlev, Denmark North Zealand Hospital, Hillerød, Denmark |
| 272 | Recruiting | The DAWN Camostat Trial for Ambulatory COVID-19 Patients | SARS-CoV Infection | Drug: Camostat Drug: Placebo |
Phase 3 | KU Leuven, Universiteit Antwerpen, University Ghent, Universite de Liege, Vrije Universiteit Brussel | OTHER | 1316 | All | 40 Years | KU Leuven, Leuven, Belgium |
| 271 | Recruiting | The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores | COVID-19 Pneumonia | Biological: Bacillus subtilis | Not Applicable | DreamTec Research Limited | INDUSTRY | 30 | All | 25 Years | Zentrogene Bioscience Laboratory Ltd, Hong Kong, Hong Kong |
| 270 | Completed | The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. | COVID-19 | Drug: Colchicine Other: Local standard of care |
Phase 3 | Estudios Clinicos Latino America, Population Health Research Institute | OTHER | 1279 | All | 18 Years | Sanatorio Parque, Rosario, Santa Fe, Argentina |
| 269 | Completed | The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19 | COVID-19 | Drug: Berberine Drug: Montmorrillonite |
Phase 4 | Chinese Medical Association | NETWORK | 76 | All | 18 Years ~ 80 Years | Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China |